Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Erbitux
Active Ingredient:	Cetuximab 5mg/mL
Dosage Form:	Solution for infusion
New Zealand Sponsor:	Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:	Merck Healthcare KGaA, Darmstadt, Germany

*Product:*	Proveblue Methylene Blue
Active Ingredient:	Methylthioninium chloride hydrate 5mg/mL equivalent to methylthioninium chloride trihydrate 5mg/mL
Dosage Form:	Solution for injection
New Zealand Sponsor:	Clinect NZ Pty Limited
Manufacturer:	Cenexi SAS, Fontenay-sous-Bois, France

Dated this 10th day of September 2024.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule